The calculator provides concentration values based on mathematical formulas
In an announcement published on 21 May 2026, Eli Lilly shared the results of the TRIUMPH-1 study, which involved 2,339 participants who were randomised to receive either retatrutide 4mg, 9mg, 12mg (building up every four weeks from 2mg), or placebo
Did the Phase 2 trial show fewer side effects than Wegovy or Zepbound
Soluble fiber sources like oats, chia seeds, and well-cooked legumes tend to be better tolerated than raw cruciferous vegetables
Tirzepatide , a dual GIP/GLP-1 receptor agonist, demonstrated superior efficacy to semaglutide in a landmark head-to-head trial, with patients receiving ZEPBOUND losing an average of 50 pounds over 72 weeks compared with 33 pounds among WEGOVY-treated patients